<?xml version='1.0' encoding='UTF-8'?>
<Organism_Record>
  <Organism_ID>ASD01630000_1</Organism_ID>
  <Organism>Human</Organism>
  <Organism_Latin>Homo sapiens</Organism_Latin>
  <UniProt_ID>P12268</UniProt_ID>
  <Seq_Length>514</Seq_Length>
  <Molecule_Weight>55805</Molecule_Weight>
  <KEGG_ID>hsa:3615</KEGG_ID>
  <Orthology_ID>K00088</Orthology_ID>
  <Function_Summary>Catalyzes the conversion of inosine 5'-phosphate (IMP) to xanthosine 5'-phosphate (XMP), the first committed and rate-limiting step in the de novo synthesis of guanine nucleotides, and therefore plays an important role in the regulation of cell growth. Could also have a single-stranded nucleic acid-binding activity and could play a role in RNA and/or DNA metabolism. It may also have a role in the development of malignancy and the growth progression of some tumors.</Function_Summary>
  <Catalytic_Mechanism>Inosine 5'-phosphate + NAD(+) + H(2)O = xanthosine 5'-phosphate + NADH.</Catalytic_Mechanism>
  <Pfam_ID>PF00571:CBS@@PF00478:IMPDH</Pfam_ID>
  <Allosteric_Activator_Count>2</Allosteric_Activator_Count>
  <Allosteric_Inhibitor_Count>2</Allosteric_Inhibitor_Count>
  <Allosteric_Regulator_Count>0</Allosteric_Regulator_Count>
  <Alias_List>
      <Alias>IMPD 2</Alias>
      <Alias>IMP (inosine monophosphate) dehydrogenase 2</Alias>
      <Alias>Inosine monophosphate dehydrogenase type II</Alias>
      <Alias>IMP oxireductase 2</Alias>
      <Alias>Inosine 5' phosphate dehydrogenase 2</Alias>
      <Alias>IMPDH 2</Alias>
  </Alias_List>
  <Function_List>
    <Funtion>
      <Detail>Interacting selectively and non-covalently with a nucleotide, any compound consisting of a nucleoside that is esterified with (ortho)phosphate or an oligophosphate at any hydroxyl group on the ribose or deoxyribose.</Detail>
      <Keyword>Nucleotide binding</Keyword>
      <Ontology_ID>GO:0000166</Ontology_ID>
    </Funtion>
    <Funtion>
      <Detail>Interacting selectively and non-covalently with any metal ion.</Detail>
      <Keyword>Metal ion binding</Keyword>
      <Ontology_ID>GO:0046872</Ontology_ID>
    </Funtion>
    <Funtion>
      <Detail>Interacting selectively and non-covalently with an RNA molecule or a portion thereof.</Detail>
      <Keyword>RNA binding</Keyword>
      <Ontology_ID>GO:0003723</Ontology_ID>
    </Funtion>
    <Funtion>
      <Detail>Catalysis of the reaction: inosine 5'-phosphate + NAD+ + H2O = xanthosine 5'-phosphate + NADH + H+.</Detail>
      <Keyword>IMP dehydrogenase activity</Keyword>
      <Ontology_ID>GO:0003938</Ontology_ID>
    </Funtion>
    <Funtion>
      <Detail>Any molecular function by which a gene product interacts selectively with DNA (deoxyribonucleic acid).</Detail>
      <Keyword>DNA binding</Keyword>
      <Ontology_ID>GO:0003677</Ontology_ID>
    </Funtion>
  </Function_List>
  <BioProcess_List>
    <BioProcess>
      <Detail>The chemical reactions and pathways involving purine bases, one of the two classes of nitrogen-containing ring compounds found in DNA and RNA, which include adenine and guanine.</Detail>
      <Keyword>Purine base metabolic process</Keyword>
      <Ontology_ID>GO:0006144</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>The chemical reactions and pathways resulting in the formation of GMP, guanosine monophosphate.</Detail>
      <Keyword>GMP biosynthetic process</Keyword>
      <Ontology_ID>GO:0006177</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>A metabolic process that results in the removal or addition of one or more electrons to or from a substance, with or without the concomitant removal or addition of a proton or protons.</Detail>
      <Keyword>Oxidation-reduction process</Keyword>
      <Ontology_ID>GO:0055114</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>The chemical reactions and pathways resulting in the formation of a purine nucleotide, a compound consisting of nucleoside (a purine base linked to a deoxyribose or ribose sugar) esterified with a phosphate group at either the 3' or 5'-hydroxyl group of the sugar.</Detail>
      <Keyword>Purine nucleotide biosynthetic process</Keyword>
      <Ontology_ID>GO:0006164</Ontology_ID>
    </BioProcess>
  </BioProcess_List>
  <PTM_List>
    <PTM>
      <Position>122</Position>
      <PTM_Type>Phosphoserine</PTM_Type>
    </PTM>
    <PTM>
      <Position>400</Position>
      <PTM_Type>Phosphotyrosine</PTM_Type>
    </PTM>
    <PTM>
      <Position>416</Position>
      <PTM_Type>Phosphoserine</PTM_Type>
    </PTM>
    <PTM>
      <Position>511</Position>
      <PTM_Type>N6-acetyllysine</PTM_Type>
    </PTM>
  </PTM_List>
  <Molecule_Seq>
    <Protein_Seq>MADYLISGGTSYVPDDGLTAQQLFNCGDGLTYNDFLILPGYIDFTADQVDLTSALTKKITLKTPLVSSPMDTVTEAGMAIAMALTGGIGFIHHNCTPEFQANEVRKVKKYEQGFITDPVVLSPKDRVRDVFEAKARHGFCGIPITDTGRMGSRLVGIISSRDIDFLKEEEHDCFLEEIMTKREDLVVAPAGITLKEANEILQRSKKGKLPIVNEDDELVAIIARTDLKKNRDYPLASKDAKKQLLCGAAIGTHEDDKYRLDLLAQAGVDVVVLDSSQGNSIFQINMIKYIKDKYPNLQVIGGNVVTAAQAKNLIDAGVDALRVGMGSGSICITQEVLACGRPQATAVYKVSEYARRFGVPVIADGGIQNVGHIAKALALGASTVMMGSLLAATTEAPGEYFFSDGIRLKKYRGMGSLDAMDKHLSSQNRYFSEADKIKVAQGVSGAVQDKGSIHKFVPYLIAGIQHSCQDIGAKSLTQVRAMMYSGELKFEKRTSSAQVEGGVHSLHSYEKRLF</Protein_Seq>
    <DNA_Seq>GAATTCGGGCGGTCCTCGGAGACACGCGGCGGTGTCCTGTGTTGGCCATGGCCGACTACCTGATTAGTGGGGGCACGTCCTACGTGCCAGACGACGGACTCACAGCACAGCAGCTCTTCAACTGCGGAGACGGCCTCACCTACAATGACTTTCTCATTCTCCCTGGGTACATCGACTTCACTGCAGACCAGGTGGACCTGACTTCTGCTCTGACCAAGAAAATCACTCTTAAGACCCCACTGGTTTCCTCTCCCATGGACACAGTCACAGAGGCTGGGATGGCCATAGCAATGGCGCTTACAGGCGGTATTGGCTTCATCCACCACAACTGTACACCTGAATTCCAGGCCAATGAAGTTCGGAAAGTGAAGAAATATGAACAGGGATTCATCACAGACCCTGTGGTCCTCAGCCCCAAGGATCGCGTGCGGGATGTTTTTGAGGCCAAGGCCCGGCATGGTTTCTGCGGTATCCCAATCACAGACACAGGCCGGATGGGGAGCCGCTTGGTGGGCATCATCTCCTCCAGGGACATTGATTTTCTCAAAGAGGAGGAACATGACTGTTTCTTGGAAGAGATAATGACAAAGAGGGAAGACTTGGTGGTAGCCCCCCGCAGCATCACACTGAAGGAGGCAAATGAAATTCTGCAGCGCAGCAAGAAGGGAAAGTTGCCCATTGTAAATGAAGATGATGAGCTTGTGGCCATCATTGCCCGGACAGACCTGAAGAAGAATCGGGACTACCCACTAGCCTCCAAAGATGCCAAGAAACAGCTGCTGTGTGGGGCAGCCATTGGCACTCATGAGGATGACAAGTATAGGCTGGACTTGCTCGCCCAGGCTGGTGTGGATGTAGTGGTTTTGGACTCTTCCCAGGGAAATTCCATCTTCCAGATCAATATGATCAAGTACATCAAAGACAAATACCCTAATCTCCAAGTCATTGGAGGCAATGTGGTCACTGCTGCCCAGGCCAAGAACCTCATTGATGCAGGTGTGGATGCCCTGCGGGTGGGCATGGGAAGTGGCTCCATCTGCATTACGCAGGAAGTGCTGGCCTGTGGGCGGCCCCAAGCAACAGCAGTGTACAAGGTGTCAGAGTATGCACGGCGCTTTGGTGTTCCGGTCATTGCTGATGGAGGAATCCAAAATGTGGGTCATATTGCGAAAGCCTTGGCCCTTGGGGCCTCCACAGTCATGATGGGCTCTCTCCTGGCTGCCACCACTGAGGCCCCTGGTGAATACTTCTTTTCCGATGGGATCCGGCTAAAGAAATATCGCGGTATGGGTTCTCTCGATGCCATGGACAAGCACCTCAGCAGCCAGAACAGATATTTCAGTGAAGCTGACAAAATCAAAGTGGCCCAGGGAGTGTCTGGTGCTGTGCAGGACAAAGGGTCAATCCACAAATTTGTCCCTTACCTGATTGCTGGCATCCAACACTCATGCCAGGACATTGGTGCCAAGAGCTTGACCCAAGTCCGAGCCATGATGTACTCTGGGGAGCTTAAGTTTGAGAAGAGAACGTCCTCAGCCCAGGTGGAAGGTGGCGTCCATAGCCTCCATTCGTATGAGAAGCGGCTTTTCTGAAAAGGGATCCAGCACACCTCCTCGGTTTTTTTTTCAATAAAAGTTTAGAAAGACCCGAATTC</DNA_Seq>
  </Molecule_Seq>
  <Tissuelocal_List>
    <TissueLocal>
      <TissueLocal>Peripheral leukocytes</TissueLocal>
    </TissueLocal>
  </Tissuelocal_List>
  <CellLocal_List>
    <AsdMacromoleculeCelllocal>
        <CellLocal>Cytoplasm</CellLocal>
    </AsdMacromoleculeCelllocal>
  </CellLocal_List>
  <Gene>
    <Gene_Name>IMPDH2</Gene_Name>
    <Gene_Alias>IMPD2</Gene_Alias>
    <Gene_ID>3615</Gene_ID>
    <Genbank_ACCN>NM_000884</Genbank_ACCN>
    <Protein_ACCN>NP_000875</Protein_ACCN>
    <HGNC_ID>6053</HGNC_ID>
    <Gene_URL>http://www.ncbi.nlm.nih.gov/gene/3615</Gene_URL>
    <UCSC_ID>uc003cvt.3</UCSC_ID>
    <EMBL_ID>ENSG00000178035</EMBL_ID>
  </Gene>
  <PDB_List>
    <PDB>
      <PDB_Title>TERNARY COMPLEX OF HUMAN TYPE-II INOSINE MONOPHOSPHATE DEHYDROGENASE WITH 6-CL-IMP AND SELENAZOLE ADENINE DINUCLEOTIDE</PDB_Title>
      <PDB_ID>1B3O</PDB_ID>
      <Resolution>2.9</Resolution>
      <PDB_URL>http://www.rcsb.org/pdb/explore/explore.do?structureId=1B3O</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <Ligand_Name>6-CHLOROPURINE RIBOSIDE, 5'-MONOPHOSPHATE $SELENAZOLE-4-CARBOXYAMIDE-ADENINE DINUCLEOTIDE $UNKNOWN ATOM OR ION</Ligand_Name>
      <PubMed_Title>Crystal structure of human type II inosine monophosphate dehydrogenase: implications for ligand binding and drug design.</PubMed_Title>
      <Author>Colby TD, et al.</Author>
      <Journal>(1999) Proc.Natl.Acad.Sci.USA 96: 3531-3536</Journal>
      <PubMed_ID>10097070</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>Ternary complex of the human type II Inosine Monophosphate Dedhydrogenase with 6Cl-IMP and NAD</PDB_Title>
      <PDB_ID>1NFB</PDB_ID>
      <Resolution>2.9</Resolution>
      <PDB_URL>http://www.rcsb.org/pdb/explore/explore.do?structureId=1NFB</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <Ligand_Name>6-CHLOROPURINE RIBOSIDE, 5'-MONOPHOSPHATE $NICOTINAMIDE-ADENINE-DINUCLEOTIDE</Ligand_Name>
      <PubMed_Title>The Conformation of NAD Bound to Human Inosine Monophosphate Dehydrogenase Type II</PubMed_Title>
      <Author>Risal D, et al.</Author>
      <Journal>To be Published</Journal>
    </PDB>
    <PDB>
      <PDB_Title>Ternary complex of the human type II Inosine Monophosphate Dedhydrogenase with Ribavirin Monophosphate and C2-Mycophenolic Adenine Dinucleotide</PDB_Title>
      <PDB_ID>1NF7</PDB_ID>
      <Resolution>2.65</Resolution>
      <PDB_URL>http://www.rcsb.org/pdb/explore/explore.do?structureId=1NF7</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <Ligand_Name>{[5-(6-AMINO-PURIN-7-YL)-3,4-DIHYDROXY-TETRAHYDRO- FURAN-2-YLMETHOXY]-HYDROXY
-PHOSPHORYLMETHYL}- PHOSPHONIC ACID MONO-[2-(4-HYDROXY-6-METHOXY- 7-METHYL-3-OXO
-1,3-DIHYDRO-ISOBENZOFURAN- 5-YL)-ETHYL] ESTER $RIBAVIRIN MONOPHOSPHATE $UNKNOWN</Ligand_Name>
      <PubMed_Title>Crystal Structure of Human Inosine Monophosphate Dehydrogenase type II complexed with the MPA/NAD analog C2-MAD</PubMed_Title>
      <Author>Risal D, et al.</Author>
      <Journal>To be Published</Journal>
    </PDB>
  </PDB_List>
  <Network_List>
    <Network>
      <Pathway_ID>ko00983</Pathway_ID>
      <Pathway_Title>Drug metabolism - other enzymes</Pathway_Title>
      <Pathway_Class>Metabolism</Pathway_Class>
      <Pathway_Subclass>Xenobiotics biodegradation and metabolism</Pathway_Subclass>
    </Network>
    <Network>
      <Pathway_ID>ko00230</Pathway_ID>
      <Pathway_Title>Purine metabolism</Pathway_Title>
      <Pathway_Class>Metabolism</Pathway_Class>
      <Pathway_Subclass>Nucleotide metabolism</Pathway_Subclass>
    </Network>
  </Network_List>
  <Fold>
    <SCOP_Class>Alpha and beta proteins (a/b)</SCOP_Class>
    <SCOP_URL>http://scop.mrc-lmb.cam.ac.uk/scop/data/scop.b.d.b.g.b.f.html</SCOP_URL>
    <CATH_Class>Mixed alpha-beta</CATH_Class>
    <CATH_URL>http://www.cathdb.info/domain/1nf7A00</CATH_URL>
  </Fold>
  <AllostericSite_List>
    <AllostericSite>
      <Site_Reference>Bruzzese FJ, et al. Biochemistry. 1997,36(34):10428-10438.</Site_Reference>
      <Site_Type>Nested subunit-subunit interactions</Site_Type>
      <PubMed_ID>9265623</PubMed_ID>
    </AllostericSite>
  </AllostericSite_List>
  <Enzyme_Nomenclature_List>
    <Enzyme_Nomenclature>
      <Enzyme_DB_ID>1.1.1.205</Enzyme_DB_ID>
      <Enzyme_DB_URL>http://www.chem.qmul.ac.uk/iubmb/enzyme/EC1/1/1/205.html</Enzyme_DB_URL>
    </Enzyme_Nomenclature>
  </Enzyme_Nomenclature_List>
  <Modulator_List>
    <Modulator>
      <ASD_ID>ASD01320076</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD01330002</ASD_ID>
      <Modulator_Feature>Activator</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD01630002</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD01630003</ASD_ID>
      <Modulator_Feature>Activator</Modulator_Feature>
    </Modulator>
  </Modulator_List>
  <Create_Date>2012-05-31</Create_Date>
</Organism_Record>